XTL Biopharmaceutica (Israel) Analysis

XTL Stock Analysis Notes

About 16.0% of the company outstanding shares are owned by insiders. The company has Price/Earnings (P/E) ratio of 558.33. XTL Biopharmaceuticals had not issued any dividends in recent years. XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. XTL Biopharmaceuticals Ltd. was founded in 1993 and is headquartered in Ramat Gan, Israel. XTL BIOPHARMACEUTI is traded on Tel Aviv Stock Exchange in Israel. For more information please call Shlomo Shalev at 972 3 611 6600 or visit https://www.xtlbio.com.

XTL Biopharmaceuticals Investment Alerts

XTL Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 236.53 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate XTL Biopharmaceutica's market, we take the total number of its shares issued and multiply it by XTL Biopharmaceutica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 3rd of December, XTL Biopharmaceutica maintains the Mean Deviation of 3.62, risk adjusted performance of (0.05), and Standard Deviation of 5.64. In relation to fundamental indicators, the technical analysis model lets you check available technical drivers of XTL Biopharmaceuticals, as well as the relationship between them.

XTL Biopharmaceuticals Price Movement Analysis

XTL Biopharmaceutica Outstanding Bonds

XTL Biopharmaceutica Predictive Daily Indicators

XTL Biopharmaceutica Forecast Models

XTL Biopharmaceutica's time-series forecasting models are one of many XTL Biopharmaceutica's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary XTL Biopharmaceutica's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how XTL Biopharmaceutica prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling XTL shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as XTL Biopharmaceutica. By using and applying XTL Stock analysis, traders can create a robust methodology for identifying XTL entry and exit points for their positions.

When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.